ATE408829T1 - Verfahren und assaykits zum nachweis mononuklearer zellphänotypen - Google Patents

Verfahren und assaykits zum nachweis mononuklearer zellphänotypen

Info

Publication number
ATE408829T1
ATE408829T1 AT00906912T AT00906912T ATE408829T1 AT E408829 T1 ATE408829 T1 AT E408829T1 AT 00906912 T AT00906912 T AT 00906912T AT 00906912 T AT00906912 T AT 00906912T AT E408829 T1 ATE408829 T1 AT E408829T1
Authority
AT
Austria
Prior art keywords
mononuclear cell
cell phenotype
amount
assay kits
methods
Prior art date
Application number
AT00906912T
Other languages
English (en)
Inventor
Emilio Barbera-Guillem
M Nelson
Original Assignee
Biocrystal Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocrystal Ltd filed Critical Biocrystal Ltd
Application granted granted Critical
Publication of ATE408829T1 publication Critical patent/ATE408829T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56972—White blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT00906912T 1999-01-14 2000-01-13 Verfahren und assaykits zum nachweis mononuklearer zellphänotypen ATE408829T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US11594699P 1999-01-14 1999-01-14
US11789599P 1999-01-29 1999-01-29
US33310399A 1999-06-15 1999-06-15
US09/435,289 US6251616B1 (en) 1999-01-14 1999-11-05 Methods and assay kits for detecting altered mononuclear cell phenotype related to a pro-tumor immune response

Publications (1)

Publication Number Publication Date
ATE408829T1 true ATE408829T1 (de) 2008-10-15

Family

ID=27494053

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00906912T ATE408829T1 (de) 1999-01-14 2000-01-13 Verfahren und assaykits zum nachweis mononuklearer zellphänotypen

Country Status (5)

Country Link
US (1) US6251616B1 (de)
EP (1) EP1151298B1 (de)
AT (1) ATE408829T1 (de)
AU (1) AU2849300A (de)
WO (1) WO2000042431A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6418338B1 (en) * 1998-02-06 2002-07-09 Phylatron Ltd. Method for detecting and surgically removing lymphoid tissue involved in tumor progression
AU6799100A (en) * 1999-08-23 2001-03-19 Biocrystal Limited Methods and assay kits for detecting a pro-ms immune response via assay of b cells
US7183388B2 (en) * 2001-03-30 2007-02-27 The Regents Of The University Of California Anti-MUC-1 single chain antibodies for tumor targeting
US20030077676A1 (en) * 2001-03-30 2003-04-24 University Of California, Davis Technology Transfer Center Anti-MUC-1 single chain antibodies for tumor targeting
US6767733B1 (en) 2001-10-10 2004-07-27 Pritest, Inc. Portable biosensor apparatus with controlled flow
US20040023415A1 (en) * 2002-03-05 2004-02-05 Konstantin Sokolov Biospecific contrast agents
AU2003226067A1 (en) * 2002-04-11 2003-10-27 Cyclex, Inc. Method for monitoring the immune response and predicting clinical outcomes in transplant recipients
US20040060987A1 (en) * 2002-05-07 2004-04-01 Green Larry R. Digital image analysis method for enhanced and optimized signals in fluorophore detection
AU2003246396B2 (en) * 2002-05-28 2008-08-21 Merck Patent Gmbh A method for generating antigen-presenting cells
DE10224825A1 (de) * 2002-06-05 2003-12-24 Eppendorf Ag Verfahren zur Analyse von Biomolekülen
GB0305422D0 (en) * 2003-03-10 2003-04-16 Univ Open Detection, monitoring and treatment of cancer
US20120077206A1 (en) 2003-07-12 2012-03-29 Accelr8 Technology Corporation Rapid Microbial Detection and Antimicrobial Susceptibility Testing
WO2005027714A2 (en) 2003-07-12 2005-03-31 Accelr8 Technology Corporation Sensitive and rapid biodetection
WO2008008349A2 (en) * 2006-07-11 2008-01-17 Drexel University Methods of quantitatively assessing inflammation with biosensing nanoparticles
JP2013533960A (ja) 2010-06-01 2013-08-29 トドス メディカル リミテッド がんの診断
GB201012297D0 (en) * 2010-07-22 2010-09-08 Ge Healthcare Uk Ltd A system and method for automated biological cell assay data analysis
US10254204B2 (en) 2011-03-07 2019-04-09 Accelerate Diagnostics, Inc. Membrane-assisted purification
ES2551922T3 (es) 2011-03-07 2015-11-24 Accelerate Diagnostics, Inc. Sistemas rápidos de purificación celular
WO2012153326A1 (en) 2011-05-11 2012-11-15 Todos Medical Ltd. Diagnosis of cancer
US9677109B2 (en) 2013-03-15 2017-06-13 Accelerate Diagnostics, Inc. Rapid determination of microbial growth and antimicrobial susceptibility
EP3004870B1 (de) 2013-05-28 2019-01-02 Todos Medical Ltd. Differentialdiagnose gutartiger tumoren
US9953417B2 (en) 2013-10-04 2018-04-24 The University Of Manchester Biomarker method
US9519823B2 (en) * 2013-10-04 2016-12-13 The University Of Manchester Biomarker method
US10253355B2 (en) 2015-03-30 2019-04-09 Accelerate Diagnostics, Inc. Instrument and system for rapid microorganism identification and antimicrobial agent susceptibility testing
EP3278115A2 (de) 2015-03-30 2018-02-07 Accelerate Diagnostics, Inc. Instrument und system zum schnellen identifizieren von mikroorganismen und testen der antimikrobiellen wirkstoffempfindlichkeit

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4511662A (en) * 1982-06-18 1985-04-16 Bio-Rad Laboratories, Inc. Simultaneous assay for T and B lymphocyte populations and subpopulations
US4599304A (en) * 1983-10-07 1986-07-08 Becton, Dickinson And Company Method for monitoring activated cell subpopulations
US5085985A (en) * 1987-11-12 1992-02-04 Becton Dickinson & Co. Monoclonal antibodies and their use in a method for monitoring subsets of activated T cells
AU3665699A (en) * 1998-04-27 1999-11-16 Biocrystal Limited Compositions and methods for tolerization in immune complex-mediated disease progression

Also Published As

Publication number Publication date
US6251616B1 (en) 2001-06-26
AU2849300A (en) 2000-08-01
WO2000042431A1 (en) 2000-07-20
EP1151298A1 (de) 2001-11-07
EP1151298A4 (de) 2002-10-24
EP1151298B1 (de) 2008-09-17

Similar Documents

Publication Publication Date Title
ATE408829T1 (de) Verfahren und assaykits zum nachweis mononuklearer zellphänotypen
DE602005013957D1 (de) Verfahren zur durchführung von vollbluttests
ATE489633T1 (de) Verfahren zum frühzeitigen nachweis herzerkrankungen
DE69522831T2 (de) Assays und vorrichtungen zum nachweis von extrahepatischer biliäreratresie
WO2003043487A3 (en) Method of using a non-antibody protein to detect and measure an analyte
GB2430740A (en) System and method for tracking and quatitating chemical entites
WO2004055519A3 (en) Specific markers for pancreatic cancer
PL1776587T3 (pl) Zastosowanie C3A i jego pochodnych jako biomarkera do leczenia gruczolaka i/lub raka jelita grubego; metody diagnostyczne i testy z ich użyciem
DK1513878T3 (da) Sammensætninger og fremgangsmåder til analyse af Apo B48 og Apo B100
DE69718268D1 (de) Verfahren zur Detektion von Zielnukleinsäure, Verfahren zu ihrer Quantifizierung und Pyrylium-Verbindungen zur Chemilumineszenz-Analyse
DK1639130T3 (da) Prober, biblioteker og kits til analyse af blandinger af nukleinsyrer og metoder til opbygning af disse
EA200500355A1 (ru) Способ обнаружения, характеристики и мониторинга углеводородных месторождений
DE60325107D1 (de) Verfahren und kit zum quantitativen und/oder qualitativen nachweis von komponenten in einer probe
ATE541048T1 (de) Verfahren und vorrichtung zum nachweisen und/oder bestimmen der in einer probe enthaltenen bakterien
NO20062280L (no) Test
CA2586654A1 (en) Use of asc as a marker for colorectal cancer
DE60038557D1 (en) Assay
ATE499612T1 (de) Verwendung eines endoplasmin-fragments und von derivaten davon als biomarker für kolorektaladenom und/oder -karzinom; nachweisverfahren und testsystem
ATE347108T1 (de) Zusammensetzungen und verfahren zum bestimmen von aa4rp
DE69033072D1 (de) Verfahren und Mittel zum Nachweis von Krankheitszuständen aus Änderungen im Östrogenstoffwechsel
HUP0203269A2 (en) Method for the detection of mammalian carcinomas
IL143639A0 (en) Method for determining the activity of a substance using a functional test in vitro
DE69928213D1 (de) Verfahren zum bestimmen humaner thymidylatsynthase und versuchskit
WO2006066592A3 (en) Probes, libraries and kits for analysis of mixtures of nucleic acids and methods for constructing the same

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties
REN Ceased due to non-payment of the annual fee